Ohio Prescription Drug Abuse Task Force
Total Page:16
File Type:pdf, Size:1020Kb
Ohio Prescription Drug Abuse Task Force Final Report Task Force Recommendations October 1, 2010 Presented to Governor Ted Strickland & The Ohio General Assembly Ohio Prescription Drug Abuse Task Force George T. Maier, Chair Dr. Alvin Jackson, Vice Chair Department of Public Safety Department of Health October 1, 2010 The Honorable Ted Strickland May 17, 2010 Governor of Ohio Statehouse Governor Ted Strickland Columbus, OH 43215 Ohio Statehouse 1 Capitol Square Dear Governor Strickland: Columbus, Ohio 43215 The Ohio Prescription Drug Abuse Task Force has completed Governorits work and Strickland, has developed 20 policy recommendations that we believe will curb Ohio’s prescription drug abuse epidemic. As Vice Chair of the Ohio Prescription Drug Abuse Task Force (OPDATF), it is my belief that The Task Force’s recommendations preserve a necessary balanceall of between the members prevention, of this grouptreatment, are motivated law and eager to continue our work on this issue. In enforcement, legislative needs, education needs and policy changes.the six weeks These since recommendations the task force was are created, the first we steps have in worked diligently to define the scope of addressing this issue from each of these critical perspectives.the We problem believe andthat have these begun recommendations discussion on addresspotential the solutions. areas of concern identified in Executive Order 2010-4S. The recommendations in this report will serve as the first step towards substantial consumer, In just six months, the Task Force has convened 10 full meetingspublic and health, 15 Work treatment Group meetings,and law enforcement with members changes that will address Ohio’s prescription drug from a diverse group of professional backgrounds and perspectives,abuse epidemic. to develop Over a report the next and few recommendations months, we will be working with our colleagues on the task to address Ohio’s complex prescription drug abuse epidemic.force These as recommendationswell as other interested reflect parties hours in workingof discussion groups. and debate and represent the consensus of the members of the Task Force. The group had an open and inclusive process, giving many individuals and professional organizationsWhile the the opportunity task force continuesto comment meet and and have develop their policy solutions that will address the epidemic statewide, the Ohio Department of Health (ODH) is continuing to address the epidemic in the concerns heard. hardest hit communities. We are funding two pilot prevention programs in Montgomery and Scioto Counties, through 2013, to develop community driven solutions to this complicated public The members of the Task Force are passionate about this issue. Many of its dedicated professionals have health issue. In addition, ODH is implementing, “Prescription for Prevention” a comprehensive committed to continuing to work on combating this epidemic in the future. Ohio is fortunate to have this social marketing program in other at risk parts of the state. committed group of leaders as we continue to work at reducing prescription drug abuse and misuse in our state. Thank you for your continued commitment to solving this epidemic. We look forward to working with you in the Thank your for your continued support and commitment to addressing this critical public health future to implement these recommendations and will continue to fight to protect and improve the well-being of issue. Ohio’s residents. Sincerely, Sincerely, George T. Maier Alvin D. Jackson M.D. Director Alvin D. Jackson, M.D. Assistant Director, Ohio Department of Public Safety Director, Ohio Department of Health Ohio Department of Health Ohio Prescription Drug Abuse Task Force Chair Ohio Prescription Drug Abuse Task Force Vice Chair Governor Ted Strickland 1970 West Broad Street • Columbus • Ohio 43223 Ohio Prescription Drug Abuse Task Force Final Report • Task Force Recommendations TABLE OF CONTENTS Executive Summary .........................................................................................................................................5 Summary of Recommendations .................................................................................................................9 Task Force Members .................................................................................................................................... 13 Ohio’s Epidemic .............................................................................................................................................. 17 Role of Prescription Pain Medications ............................................................................................. 19 How Did This Become an Epidemic? ................................................................................................ 21 Impact of the Epidemic on Law Enforcement ............................................................................... 24 Impact of the Epidemic on Treatment ............................................................................................. 27 Impact of the Epidemic on Public Health ...................................................................................... 28 Impact of the Epidemic on Healthcare Professionals ................................................................. 30 Law Enforcement Recommendations ................................................................................................... 33 Treatment Recommendations .................................................................................................................. 41 Regulatory Recommendations ................................................................................................................. 49 Public Health Recommendations ........................................................................................................... 61 Task Force Progress ....................................................................................................................................... 69 Appendix: Additional Participants .......................................................................................................................... 73 Letters of Support from Professional Organizations .................................................................. 75 Executive Order ........................................................................................................................................ 83 Sources ........................................................................................................................................................ 88 1 Executive Summary Ohio Prescription Drug Abuse Task Force Final Report • Task Force Recommendations EXECUTIVE SUMMARY On April 2, 2010, Governor Ted Strickland signed Executive Order 2010-4S, establishing the Ohio Prescription Drug Abuse Task Force (the “Task Force”). The Task Force was created to develop a coordinated and comprehensive approach to Ohio’s prescription drug abuse epidemic. The group was comprised of 33 members with a wide range of professional backgrounds and perspectives, including: state and local public health officials, health provider board and association representatives, state and local law enforcement, local government officials, state agency representatives and legislators. The Task Force was charged with meeting regularly to develop and recommend potential remedies to the growing misuse and abuse of prescription drugs in Ohio. Due to the urgency of this problem, the Task Force was required to submit an initial progress report to the Governor and the leaders of the Ohio General Assembly by May 17, 2010. The progress report included initial recommendations encouraging support for community education efforts (i.e. drug take back programs and social marketing campaigns) and charged the Task Force Work Groups to explore and identify potential solutions for the Task Force Final Report. Since the submission of the initial progress report, the Task Force and its Work Groups met frequently and have developed 20 recommendations. In order to ensure the state’s approach is both multifaceted and comprehensive, the recommendations address issues related to treatment, law enforcement, public health and regulation. In accordance with Executive Order 2010-4S, and in support of the Governor’s mission to reduce prescription drug abuse in Ohio, the Task Force hereby issues this final report. 5 Summary of Recommendations SUMMARY OF RECOMMENDATIONS 9 Task Force Members Ohio Prescription Drug Abuse Task Force Final Report • Task Force Recommendations TASK FORCE MEMBERS Task Force Chair Jeff Davis Matthew Kanai, Esq. George Maier, Assistant Director Representing: Ohio Association of Health Representing: Ohio Attorney General’s Office Ohio Department of Public Safety Plans Keith R. Kerns, Esq. Task Force Vice Chair Steven M. Dettelbach, U.S. Attorney Representing: Ohio Dental Association Alvin D. Jackson, M.D., Director Northern District of Ohio Ohio Department of Health U.S. Department of Justice Representative Clayton Luckie Ohio House of Representatives Angela Cornelius Dawson, Director Cynthia Callender Dungey Ohio Dept. of Alcohol and Drug Addiction Representing: Ohio Department of Job and Sergeant Richard Meadows Services Family Services Representing: Ohio State Highway Patrol Aaron Adams, D.O. Kort M. Gronbach, M.D. Michael A. Moné, BPharm, JD, FAPhA Representing: Association of Ohio Health Representing: Ohio State Medical Association Representing: